We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Amgen is hoping a Delaware judge will be more agreeable than a California court as it sues Hospira to slow the biosimilar maker from marketing its challenger to Epogen. Read More
Palatin Technologies and its partner Gedeon Richter have terminated their collaboration agreement to develop bremelanotide to treat female sexual dysfunction following last month’s FDA approval of Sprout Pharamceuticals’ Addyi for the same indication. Read More
The two frontrunners for the Democratic presidential nomination, Hillary Clinton and Sen. Bernie Sanders of Vermont, released prescription drug policy proposals on Tuesday that would cut prices and end “pay-for-delay” deals. Read More
A 5,000 percent price hike for the only drug indicated for treating a specific type of parasitic infection – and one that is critical for patients with lowered immune systems – is drawing howls from the public. Read More
Antibiotics developer Cempra said Friday the FDA granted a qualified infectious disease product designation for its investigational candidate Taksta to treat acute bacterial skin and skin structure infections. Read More
The FDA granted fast track designation to a drug from Mapp Biopharmaceutical to treat the Ebola virus and to Dimension Therapeutics to treat patients with hemophilia B. Read More